While Alpha-fetoprotein (AFP) is a widely used diagnostic biomarker for HCC, its limited sensitivity and specificity, as evidenced by the presence of AFP-negative HCC patients, indicates a need for improvement (Wang and Wei, 2020). Here, AFP is linked to hepatocellular carcinoma.